/

SVA.TO

SERNOVA BIOTHERAPEUTICS INCClosed

0.1150+0.01 +4.55%CAD

Toronto · as of Oct 14, 15:54 ET · 15m delay

Open

0.1150

Prev close

0.1100

Day range

0.10500.1200

52-week range

0.09000.2000

Volume

130.24K0.61×

Mkt cap

43.43M

P/E ttm

11.50

Fwd P/E

-3.83

EPS ttm

0.0100

Div yield

0.00%

Earnings

—

From 52w high

−42.50%

Price Chart

Yahoo Finance · delayed

SVA.TOOct 14, 2026O 0.1150H 0.1200L 0.1050C 0.1150+0.0050 (+4.55%)Vol 130.24K

SMA 500.1115
SMA 2000.1422

1Y change −32.35% since Oct 10, 2025 close539 bars loadedTimes in America/TorontoDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

SVA.TO SERNOVA BIOTHERAPEUTICS INC · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −4.17%
1 month: +4.55%
3 months: −4.17%
6 months: −36.11%
Year to date: −11.54%
1 year: −32.35%

Valuation & ownership

Market cap: 43.43M
Enterprise value: 57.97M
P/E (ttm): 11.50
Forward P/E: -3.83
PEG ratio: —
Price / book: —
Price / sales (ttm): —
EV / EBITDA: -6.49
EPS (ttm): 0.0100
EPS (forward): -0.0300
Beta (5y monthly): 0.64
Dividend yield: 0.00%
Payout ratio: 0.00%
Shares outstanding: 377.64M
Float: 336.77M
Short % of float: —
Short ratio (days): 1.71
Held by insiders: 10.51%
Held by institutions: 0.04%
Avg volume (3m): 215.08K
50-day average: 0.1114
200-day average: 0.1423
52-week change: −32.35%
S&P 500 52-week: +17.00%

Technicals (daily)

RSI (14): 53.1
vs 50-day SMA: +3.14%
vs 200-day SMA: −19.11%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 9.28%
Realised vol (20d, ann.): 106.6%
From 52-week high: −42.50%
From 52-week low: +27.78%

ANR

Analyst Consensus

1 analysts

Consensus

—

Mean target

1.00

+769.57% implied

Low 1.00Median 1.00High 1.00

Recommendation trend

Now2 / 0 / 0

Buy / hold / sell counts

Financial Snapshot

Full statements →trailing twelve months

DES

About SERNOVA BIOTHERAPEUTICS INC

Yahoo Finance profile

Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.

Sector: Healthcare
Industry: Biotechnology
Employees: 8
Headquarters: Mississauga, ON, Canada
Website: sernova.com
Officers: Mr. Jonathan M. N. Rigby M.B.A. President, CEO & Director
Mr. James T. Parsons CPA-CA, MAcc Chief Financial Officer
Ms. Marylyn Rigby Chief Communications Officer
Dr. Pericles Calias Ph.D. Chief Development Officer and Head of R&D

SEAS

Seasonality · SVA.TO

2007–2026 · monthly returns

Strongest month Apr +17.83%Weakest month Mar −8.45%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	23.1	-12.5	7.1	13.3	-17.6	0.0	-21.4	0.0	0.0	4.5			−11.5%
2025	-4.3	-9.1	-20.0	25.0	-10.0	-11.1	25.0	-10.0	0.0	-16.7	6.7	-18.8	−43.5%
2024	-10.0	-4.8	-10.0	-22.2	-11.9	-8.1	-20.6	0.0	-11.1	4.2	-8.0	0.0	−67.1%
2023	44.3	-10.5	-11.8	2.2	-9.8	15.7	-5.2	-7.7	-4.8	-5.0	-5.3	-2.8	−11.4%
2022	-12.1	-7.5	-2.7	0.0	2.8	-20.3	-7.6	-1.8	-21.5	-4.8	-5.0	3.9	−56.6%
2021	103.0	10.3	-2.0	-6.1	-2.9	8.2	-11.0	0.8	-3.8	0.0	4.0	40.0	+171.6%
2020	0.0	-5.9	-25.0	16.7	42.9	40.0	7.1	-3.3	-3.4	-3.6	11.1	123.3	+294.1%
2019	-10.0	-5.6	-5.9	43.8	0.0	8.7	-28.0	11.1	30.0	-23.1	0.0	-15.0	−15.0%
2018	-4.8	-5.0	-5.3	-11.1	-12.5	-21.4	0.0	-4.5	4.8	-18.2	27.8	-13.0	−52.4%
2017	-13.3	-3.8	4.0	3.8	-14.8	0.0	-8.7	0.0	-9.5	36.8	-3.8	68.0	+40.0%
2016	-13.8	-8.0	8.7	12.0	25.0	-17.1	17.2	-17.6	7.1	-3.3	-13.8	20.0	+3.4%
2015	42.9	-10.0	5.6	-5.3	5.6	47.4	-3.6	-18.5	40.9	-12.9	-14.8	26.1	+107.1%
2014	7.7	100.0	0.0	-7.1	-7.7	0.0	-16.7	10.0	-9.1	-10.0	-16.7	-6.7	+7.7%
2013	-5.9	-6.2	13.3	-17.6	-7.1	-15.4	0.0	9.1	16.7	0.0	-21.4	18.2	−23.5%
2012	15.4	6.7	-18.8	92.3	-16.0	-14.3	0.0	5.6	0.0	-5.3	0.0	-5.6	+30.8%
2011	-11.8	13.3	23.5	-9.5	-15.8	0.0	0.0	-6.2	-26.7	27.3	-14.3	8.3	−23.5%
2010	46.2	0.0	-15.8	-6.2	6.7	-18.8	-7.7	0.0	25.0	20.0	0.0	-5.6	+30.8%
2009	20.0	0.0	-50.0	200.0	22.2	9.1	66.7	-15.0	-23.5	-23.1	0.0	30.0	+160.0%
2008	-25.0	9.1	-19.4	17.2	-47.1	50.0	-25.9	-20.0	-37.5	50.0	-53.3	-28.6	−88.6%
2007	120.0	44.3	-29.1	11.1	-17.0	-1.2	-19.5	-33.3	36.4	20.0	-43.1	7.3	+10.0%

INSD

Insider Activity · SVA.TO

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Jul 2, 2026	Sernova Biotherapeutics Inc.Issuer	—	115K	—
Apr 15, 2026	Sangha (Steven)Director of Issuer	Acquisition under a prospectus exemption at price 0.11 per share.	26.67M	$2.91M
Apr 13, 2026	Parsons (James T Cpa)Director of Issuer	Acquisition under a prospectus exemption at price 0.14 per share.	229.9K	$31.72K
Apr 13, 2026	Rigby (Jonathan M N)Director of Issuer	Acquisition under a prospectus exemption at price 0.14 per share.	229.9K	$31.72K

SVA.TO

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

SVA.TO

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About SERNOVA BIOTHERAPEUTICS INC

Seasonality · SVA.TO

Insider Activity · SVA.TO

Congress Trades · SVA.TO

Investors Holding SVA.TO

Investors Holding SVA.TO

Congress Trades · SVA.TO

Insider Activity · SVA.TO

Seasonality · SVA.TO

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

Financial Snapshot

About SERNOVA BIOTHERAPEUTICS INC

Earnings & Dividends

News